Volume 36, Issue 1 (4-2025)
Studies in Medical Sciences 2025, 36(1): 26-39 |
Back to browse issues page
Ethics code: 11645
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Radvar M, Manafpour N, Zolfi A, Vazifekhah S. Investigation of serum vitamin D levels in mothers of infants with congenital heart diseases in Urmia city in 2023. Studies in Medical Sciences 2025; 36 (1) :26-39
URL: http://umj.umsu.ac.ir/article-1-6412-en.html
URL: http://umj.umsu.ac.ir/article-1-6412-en.html
Maternal and Child Obesity Research Center, Urmia University of Medical Sciences, Urmia, Iran (Corresponding Author) , shabnam.vazifekhah@yahoo.com
Abstract: (324 Views)
Background & Aims: Vitamin D can play a vital role in fetal heart development. This study investigated serum vitamin D levels in mothers of infants with congenital heart diseases.
Materials & Methods: This study was a case-control study in which 50 mothers of infants with congenital heart defects (case group) and 50 mothers of healthy infants (control group) were examined. The required information for the study included maternal age, vitamin D supplementation, duration of supplementation, family history of congenital heart disease, and serum vitamin D levels. The collected information was then analyzed..
Results: The mean serum vitamin D level in the case group was higher than the control group, but there was no statistically significant difference (P = 0.182). There was no significant relationship between the severity of vitamin D deficiency and the presence of congenital heart disease. (P = 0.695). The mean serum vitamin D level in the cyanotic group was higher than the asiatic group, but there was no significant difference according to the independent t-test (P = 0.42). Also, there was no significant relationship between the severity of vitamin D deficiency in the mother and cyanotic or asiatic status of the newborn (P = 0.102). The duration of vitamin D supplementation in the case group was slightly longer than in the control group and was significantly associated with the presence of heart defects in the newborn (P = 0.026). In the case group, there were more people with a history of congenital heart disease in their first-degree relatives than in the control group and was significantly associated with the presence of congenital heart disease in the newborn (P < 0.001).
Conclusion: In this study, significant relationship was found between vitamin D supplementation and its blood level in the mother with congenital heart disease in the newborn. However, since vitamin D deficiency in the body can cause serious complications in the individual, it is recommended that pregnant women, especially in the first trimester of pregnancy, consume sufficient vitamin D supplements.
Materials & Methods: This study was a case-control study in which 50 mothers of infants with congenital heart defects (case group) and 50 mothers of healthy infants (control group) were examined. The required information for the study included maternal age, vitamin D supplementation, duration of supplementation, family history of congenital heart disease, and serum vitamin D levels. The collected information was then analyzed..
Results: The mean serum vitamin D level in the case group was higher than the control group, but there was no statistically significant difference (P = 0.182). There was no significant relationship between the severity of vitamin D deficiency and the presence of congenital heart disease. (P = 0.695). The mean serum vitamin D level in the cyanotic group was higher than the asiatic group, but there was no significant difference according to the independent t-test (P = 0.42). Also, there was no significant relationship between the severity of vitamin D deficiency in the mother and cyanotic or asiatic status of the newborn (P = 0.102). The duration of vitamin D supplementation in the case group was slightly longer than in the control group and was significantly associated with the presence of heart defects in the newborn (P = 0.026). In the case group, there were more people with a history of congenital heart disease in their first-degree relatives than in the control group and was significantly associated with the presence of congenital heart disease in the newborn (P < 0.001).
Conclusion: In this study, significant relationship was found between vitamin D supplementation and its blood level in the mother with congenital heart disease in the newborn. However, since vitamin D deficiency in the body can cause serious complications in the individual, it is recommended that pregnant women, especially in the first trimester of pregnancy, consume sufficient vitamin D supplements.
Type of Study: Research |
Subject:
قلب کودکان
References
1. Houyel L, Meilhac SM. Heart Development and Congenital Structural Heart Defects. Annu Rev Genomics Hum Genet 2021;22:257-84. [DOI:10.1146/annurev-genom-083118-015012] [PMID]
2. Institute of Medicine (US). Cardiovascular Disability: Updating the Social Security Listings. National Academies Press; 2010. [DOI: 10.17226/12940]
3. Nezami A, Heidari G, Tarhani F, Kariminia M. Prevalence of Congenital Heart Disease among Children in Khorramabad (West of Iran). Cardiovasc Hematol Disord Drug Targets 2021;21(1):61-5. [DOI:10.2174/1871529X20999201231205746] [PMID]
4. Sun R, Liu M, Lu L, Zheng Y, Zhang P. Congenital Heart Disease: Causes, Diagnosis, Symptoms, and Treatments. Cell Biochem Biophys 2015;72(3):857-60. [DOI:10.1007/s12013-015-0551-6] [PMID]
5. Mokhtar WA, Fawzy A, Allam RM, Amer RM, Hamed MS. Maternal vitamin D level and vitamin D receptor gene polymorphism as a risk factor for congenital heart diseases in offspring; An Egyptian case-control study. Genes Dis 2019;6(2):193-200. [DOI:10.1016/j.gendis.2018.08.001] [PMID] []
6. Badfar G, Shohani M, Mansouri A, Soleymani A, Azami M. Vitamin D status in Iranian pregnant women and newborns: a systematic review and meta-analysis study. Expert Rev Endocrinol Metab 2017;12(5):[pages not provided]. [DOI:10.1080/17446651.2017.1365596] [PMID]
7. Gezmish O, Tare M, Parkington HC, Morley R, Porrello ER, Bubb KJ, et al. Maternal vitamin D deficiency leads to cardiac hypertrophy in rat offspring. Reprod Sci 2010;17(2):168-76. [DOI:10.1177/1933719109349536] [PMID]
8. Eremkina AK, Mokrysheva NG, Pigarova EA, Mirnaya SS. Vitamin D: effects on pregnancy, maternal, fetal and postnatal outcomes. Ter Arkh 2018;90(10):115-27. [DOI:10.26442/terarkh201890104-127] [PMID]
9. Kiely ME, Wagner CL, Roth DE. Vitamin D in pregnancy: Where we are and where we should go. J Steroid Biochem Mol Biol 2020;201:105669. [DOI:10.1016/j.jsbmb.2020.105669] [PMID]
10. Arjmandnia MH, Vahedian M, Yyosefi M, Amouei M, Rezvan S, Assi MH, et al. Relationship between vitamin D consumption during pregnancy and neonatal congenital heart disease. J Vessel Circ 2020;1(3):13-7. [DOI:10.52547/jvesselcirc.1.3.13]
11. Koster MPH, van Duijn L, Krul-Poel YHM, Laven JS, Helbing WA, Simsek S, et al. A compromised maternal vitamin D status is associated with congenital heart defects in offspring. Early Hum Dev 2018;117:50-6. [DOI:10.1016/j.earlhumdev.2017.12.011] [PMID]
12. Botto LD, Mulinare J, Erickson JD. Occurrence of congenital heart defects in relation to maternal multivitamin use. Am J Epidemiol 2000;151(9):878-84. [DOI:10.1093/oxfordjournals.aje.a010291] [PMID]
13. Dilli D, Doğan NN, Örün UA, Koç M, Zenciroğlu A, Karademir S, et al. Maternal and neonatal micronutrient levels in newborns with CHD. Cardiol Young 2018;28(4):523-9. [DOI:10.1017/S1047951117002372] [PMID]
14. Salehi F, Zangouei A, Zia Z, Taheribojd F, Salehi S, Khosravi Bizhaem S, et al. Investigating Vitamin D Serum Levels in Children with Congenital Heart Disease Compared with the Healthy Control Group. Int J Pediatr 2020;8(3):11077-85. [Google Scholar]
15. Noori NM, Nakhaee Moghadam M, Teimouri A, Pakravan A. 25-hydroxy Vitamin D Serum levels in Congenital Heart Disease (CHD) Children Compared to Controls. [Conference abstract] 2018. [URL:]
16. Mohamed SAR, El Barbary MN, Ahmed WO, El Maksoud SSA, Ibrahim ZH, Hashem HE, et al. Impact of Maternal and Neonatal Vitamin D Status on the Development of Congenital Anomalies in Egyptian Model. Open Access Maced J Med Sci 2022;10(B):457-63. [DOI:10.3889/oamjms.2022.7809]
17. Maiya S, Sullivan I, Allgrove J, et al. Hypocalcaemia and vitamin D deficiency: an important, but preventable, cause of life-threatening infant heart failure. Heart 2008;94:581-4. [DOI:10.1136/hrt.2007.119792] [PMID]
18. Arora S, Goel P, Chawla D, Huria A, Arya A. Vitamin D Status in Mothers and Their Newborns and Its Association with Pregnancy Outcomes: Experience from a Tertiary Care Center in Northern India. J Obstet Gynaecol India 2018;68(5):389-93. [DOI:10.1007/s13224-017-1067-3] [PMID] []
19. Chen B, Chen Y, Xu Y. Vitamin D deficiency in pregnant women: Influenced by multiple risk factors and increase the risks of spontaneous abortion and small-for-gestational age. Medicine (Baltimore) 2021;100(41):e27505. [DOI:10.1097/MD.0000000000027505] [PMID] []
20. Hatami G, Ahmadi A, Motamed N, Eghbali SS, Amirani S. 25-oh vitamin d serum level in pregnant women in bushehr- 2012. Iran South Med J 2014;16(6):410-8. [Google Schoolar]
21. Hashemipour S, Lalooha F, Zahir Mirdamadi S, Ziaee A, Dabaghi Ghaleh T. Effect of vitamin D administration in vitamin D-deficient pregnant women on maternal and neonatal serum calcium and vitamin D concentrations: a randomised clinical trial. Br J Nutr 2013;110(9):1611-6. [DOI:10.1017/S0007114513001244] [PMID]
22. Mithal A, Kalra S. Vitamin D supplementation in pregnancy. Indian J Endocrinol Metab 2014;18(5):593-6. [DOI:10.4103/2230-8210.139204] [PMID] []
23. Hollis BW, Johnson D, Hulsey TC, Ebeling M, Wagner CL. Vitamin D supplementation during pregnancy: Double-blind, randomized clinical trial of safety and effectiveness. J Bone Miner Res 2011;26(10):2341-57. [DOI:10.1002/jbmr.463] [PMID] []
24. American Heart Association. About Congenital Heart Defects. [Internet] [cited year]. Available from: https://www.heart.org/en/health-topics/congenital-heart-defects/about-congenital-heart-defects [Google Scholar]
25. Pérez-López FR, Pilz S, Chedraui P. Vitamin D supplementation during pregnancy: an overview. Curr Opin Obstet Gynecol 2020;32(5):316-21. [DOI:10.1097/GCO.0000000000000641] [PMID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
